Increased serum TNF-α levels in stages II and III patients were associated with breast cancer cell invasiveness and poor prognosis, while there was a strong association between breast cancer prognosis and the expression levels of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER)-2/neu [40]. The gene discussed is ESR1; the disease is breast cancer.